Company: BDRX
Filing Date: 2025-09-26
Form Type: F-3
Source: 0001214659-25-014255
Chunk: 28

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-09-26
Form: F-3
Chunk 28
---
 Shares with a weighted average remaining life of 0.3 years.

Warrants

May 2020 Warrants

In May 2020, we completed
a private placement with certain institutional investors, or the May Private Placement, where we issued warrants to certain investors,
or the May Private Placement Warrants. The following is a brief summary of the May Private Placement Warrants , and is subject in all
respects to the provisions contained in the warrants, which are filed as exhibits to our Report on Form 6-K dated May 20, 2020. All other
warrants issued in the May Private Placement have expired.

Exercisability.The
warrants became exercisable upon issuance. The warrants will expire on November 20, 2025.

Cashless Exercise.
If there is no effective registration statement registering, or no current prospectus available for, the resale of the Depositary Shares
underlying such warrants, the holder may exercise the warrant, in whole or in part, on a cashless basis.

Exercise Price.The
exercise price of each May Private Placement Warrant is $80,000.00 per Depositary Share, respectively, subject to the `cashless exercise’
arrangements described above and to adjustment as described below.

Beneficial Ownership Limitation.A holder shall have no right to exercise any portion of a warrant, to the extent that, after giving effect to such exercise, such
holder, together with such holder’s affiliates, and any persons acting as a group together with such holder or any such affiliate,
would beneficially own in excess of, at the initial option of the holder thereof, 4.99% or 9.99%, as applicable, of the number of Ordinary
Shares outstanding immediately after giving effect to the issuance of the Ordinary Shares underlying the Depositary Shares upon such exercise.
The holder of the warrant, upon notice to us, may increase or decrease the beneficial ownership limitation to a percentage not to exceed
9.99%, provided that any increase in the beneficial ownership limitation shall not be effective until 61 days following notice to us.
Beneficial ownership of the holder and its affiliates will be determined in accordance with Section 13(d) of the Exchange Act, and the
rules and regulations promulgated thereunder.

Stock dividends and stock splits.If we pay a stock dividend or otherwise make a distribution payable in Depositary Shares or Ordinary Shares, or any other
equity or equivalent securities, subdivide or combine outstanding Depositary Shares or Ordinary Shares, or re